flolan 0.5 mg powder and solvent for solution for infusion
glaxosmithkline (ireland) limited - epoprostenol - powder and solvent for solution for infusion - 0.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
veletri powder for solution for infusion 0.5mgvial
johnson & johnson international (singapore) pte ltd - epoprostenol sodium 0.531mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 0.531mg eqv epoprostenol 0.5mg
veletri powder for solution for infusion 1.5mgvial
johnson & johnson international (singapore) pte ltd - epoprostenol sodium 1.593mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 1.593mg eqv epoprostenol 1.5mg
heparin injection 25000iu/5ml heparin sodium injection (porcine mucous)
pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.
heparin injection 5000iu/5ml heparin sodium injection (porcine mucous)
pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.
dbl™ heparin sodium injection bp
pfizer new zealand limited - heparin sodium 1000 iu/ml; heparin sodium 1000 iu/ml - solution for injection - 1000 iu/ml - active: heparin sodium 1000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection active: heparin sodium 1000 iu/ml excipient: benzyl alcohol hydrochloric acid sodium hydroxide water for injection
dbl™ heparin sodium injection bp
pfizer new zealand limited - heparin sodium 25000 iu/ml - solution for injection - 25000 iu/ml - active: heparin sodium 25000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection
dbl™ heparin sodium injection bp
pfizer new zealand limited - heparin sodium 5000 iu/ml; heparin sodium 5000 iu/ml - solution for injection - 5000 iu/ml - active: heparin sodium 5000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection active: heparin sodium 5000 iu/ml excipient: benzyl alcohol hydrochloric acid sodium hydroxide water for injection
heparin sodium (baxter)
baxter healthcare ltd - heparin sodium 2 iu/ml - solution for infusion - 2 u/ml - active: heparin sodium 2 iu/ml excipient: citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium chloride water for injection - heparin sodium intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.
heparin sodium (pfizer)
pfizer new zealand limited - heparin sodium 5000 iu/ml; - solution for injection - 25000 iu/5ml - active: heparin sodium 5000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection